Approval · Notice of Compliance 3339 · 1997
DURATOCIN: Notice of Compliance 3339
Issued June 24, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3339
- Date
- June 24, 1997
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Uterotonic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DURATOCIN | 02231593 | Cancelled Post Market |
Medicinal ingredients
- CARBETOCIN 100 MCG per ML